RBI Maintains Optimism on FY26 Growth; Morgan Stanley Flags Tariff-Driven Headwinds

New Delhi, August 6, 2025 — The Reserve Bank of India (RBI) has retained its FY26 GDP growth forecast at 6.5% year-on-year, citing resilient domestic demand and easing inflationary pressures. However, global brokerage Morgan Stanley has issued a more cautious outlook, projecting India’s growth to moderate to 5.9% in the December 2025 quarter, citing weakening…

Read More

TSG Bhasker Raises Alarm Over Urological Equipment Shortage at GB Pant Hospital

Port Blair, August 6, 2025 — TSG Bhasker, Chairman of the ANTCC Campaign Committee, has publicly flagged a critical shortage of urological and surgical equipment at G.B. Pant Hospital, Port Blair, following a surprise inspection conducted over the weekend. The visit, aimed at assessing patient care and infrastructure readiness, revealed alarming gaps in essential medical…

Read More

Kartavya Bhawan is inaugurated by PM Modi as a modern hub for key ministries

Kartavya Bhawan is a state-of-the-art office building in Delhi’s major Vista that Prime Minister Narendra Modi is scheduled to open. Its goal is to revolutionize the way India’s major ministries operate. The Department of Personnel and Training (DoPT), the Office of the Principal Scientific Adviser, the Ministry of Home Affairs, the Department of External Affairs,…

Read More

Bharti Airtel Q1 FY26 Results: Strong Profit and Revenue Growth Driven by India Operations

New Delhi, August 5, 2025 — Bharti Airtel Ltd. has reported robust financial performance for the first quarter of FY26, with consolidated net profit surging 43% year-on-year to ₹5,948 crore, up from ₹4,160 crore in the same period last year. The telecom major’s consolidated revenue from operations rose 28.4% YoY to ₹49,463 crore, reflecting strong…

Read More

Hydrogel Breakthrough Could Extend Effectiveness of Ozempic and Similar Drugs

Scientists have developed an innovative injectable hydrogel that could significantly reduce the frequency of dosing for popular diabetes and weight-loss drugs like Ozempic (semaglutide) and Mounjaro (tirzepatide). The new delivery system, tested in rats, promises to transform treatment regimens by replacing weekly injections with potentially quarterly ones. The hydrogel, created by a team led by…

Read More